Flex Pharma Inc. | Key People and Executives
William K. McVicar
President, Chief Executive Officer & Director
Roger D. Tung
Independent Director
Michelle V. Stacy
Independent Director
Stuart Allen Randle
Lead Independent Director
Marc D. Kozin
Independent Director
Peter Barton Hutt
Independent Director
William K. McVicar
President, Chief Executive Officer & Director
John McCabe
Chief Financial Officer, Secretary & Treasurer
Glenn Short
VP-Research & Translational Development
Elizabeth Woo
SVP-Investor Relations & Corporate Communications
Roger D. Tung
Independent Director
Michelle V. Stacy
Independent Director
Stuart Allen Randle
Lead Independent Director
Marc D. Kozin
Independent Director
Peter Barton Hutt
Independent Director
| Address |
31 St. James Avenue
Boston Massachusetts 02116
United States
|
|
Employees
|
- |
| Website |
http://www.flex-pharma.com |
| Updated |
07/08/2019 |
| Flex Pharma, Inc. operates as a biotechnology company. It engages in developing treatments for exercise-associated muscle cramps, nocturnal leg cramps and spasms associated with severe neuromuscular conditions. The company operates through the following business segments: Consumer Operations and Drug Development. |
